Gaelle Auge

Nice, 06107, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Nifuroxazide rescues the deleterious effects due to CHCHD10-associated MICOS defects in disease models.

Nifuroxazide rescues the deleterious effects due to CHCHD10-associated MICOS defects in disease models.

Journal: Brain : a journal of neurology

Published: February 23, 2024

CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability.

CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability.

Journal: Brain : a journal of neurology

Published: July 27, 2021

Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ mouse.

Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ mouse.

Journal: Acta neuropathologica

Published: December 14, 2018

Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.

Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.

Journal: Neurobiology of disease

Published: February 16, 2018

Reply: High prevalence of CHCHD10 mutations in patients with frontotemporal dementia from China.

Reply: High prevalence of CHCHD10 mutations in patients with frontotemporal dementia from China.

Journal: Brain : a journal of neurology

Published: January 01, 2016

CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.

CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.

Journal: EMBO molecular medicine

Published: December 16, 2015

CHCHD10 mutations are not a common cause of SMN1-negative type III/IV spinal motor atrophy.

CHCHD10 mutations are not a common cause of SMN1-negative type III/IV spinal motor atrophy.

Journal: Annals of neurology

Published: June 23, 2015

Inactivation of Pif1 helicase causes a mitochondrial myopathy in mice.

Inactivation of Pif1 helicase causes a mitochondrial myopathy in mice.

Journal: Mitochondrion

Published: May 22, 2015

Reply: Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?

Reply: Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?

Journal: Brain : a journal of neurology

Published: May 09, 2015

Reply: A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation.

Reply: A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation.

Journal: Brain : a journal of neurology

Published: February 15, 2015

Letter to the Editor on a paper by Hsiao C-T, Tsai P-C, Liao Y-C, Lee Y-C, Soong B-W. C9ORF72 repeat expansion is not a significant cause of late-onset cerebellar ataxia syndrome. J Neurol Sci 2014;347:322-324.

Letter to the Editor on a paper by Hsiao C-T, Tsai P-C, Liao Y-C, Lee Y-C, Soong B-W. C9ORF72 repeat expansion is not a significant cause of late-onset cerebellar ataxia syndrome. J Neurol Sci 2014;347:322-324.

Journal: Journal of the neurological sciences

Published: February 11, 2015

Reply: CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis.

Reply: CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: January 11, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026